AngioDynamics Inc.
Organization details
- Legal name
- AngioDynamics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Latham
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- May
- Ticker symbol
- ANGO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001275187
- EIN
- 11-3146460
Board of directors
-
Dennis S. Meteny · DirectorSince 2023
-
Eileen O'Shea Auen · DirectorSince 2023
-
Eric Honroth · Director · President and CEOSince 2026
-
Howard W. Donnelly · DirectorSince 2023
-
James C. Clemmer · Director · President and CEOSince 2023
-
Jan Stern Reed · DirectorSince 2023
-
Karen A. Licitra · DirectorSince 2023
-
Lorinda Burgess · DirectorSince 2023
-
Michael E. Tarnoff · DirectorSince 2023
-
Wesley Johnson · DirectorSince 2023
Chief executives
Director election results
Annual meeting of November 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.1%
-
97.4%
Board connections
3 of this board's directors also sit on 3 other boards. 1 is in the same sector.
-
Avita Medical Inc. Same sectorvia Jan Stern Reed and Michael E. Tarnoff
- via Jan Stern Reed and Lorinda Burgess
- via Jan Stern Reed
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $654,695
- 3 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Eric Honroth Director, Officer (President and CEO) | Grant or award | +62,928 | — | — |
| Nov 2, 2026 | Eric Honroth Director, Officer (President and CEO) | Grant or award | +38,265 | — | — |
| Oct 29, 2026 | Trowbridge Stephen A Officer (EVP and CFO) | Open-market sale | −23,615 | $12.27 | $289,756 |
| Oct 28, 2026 | Trowbridge Stephen A Officer (EVP and CFO) | Open-market sale | −1,720 | $12.17 | $20,932 |
| Jul 30, 2026 | Nighan Warren JR Officer (SVP Quality and Regulatory) | Open-market sale | −23,370 | $14.72 | $344,006 |
| Jul 22, 2026 | Campbell Chad Thomas Officer (SVP/GM, Vascular Access) | Option exercise | +6,466 | — | — |
| Jul 22, 2026 | James C. Clemmer Director, Officer (President and CEO) | Option exercise | +52,358 | — | — |
| Jul 22, 2026 | Trowbridge Stephen A Officer (EVP and CFO) | Option exercise | +16,296 | — | — |
| Jul 22, 2026 | Nighan Warren JR Officer (SVP Quality and Regulatory) | Option exercise | +5,694 | — | — |
| Jul 22, 2026 | Piccinini Laura Officer (SVP International) | Option exercise | +8,047 | — | — |
| Jul 22, 2026 | Campbell Chad Thomas Officer (SVP/GM, Vascular Access) | Shares withheld for tax | −2,330 | $13.82 | $32,201 |
| Jul 22, 2026 | James C. Clemmer Director, Officer (President and CEO) | Shares withheld for tax | −26,728 | $13.82 | $369,381 |
| Jul 22, 2026 | Trowbridge Stephen A Officer (EVP and CFO) | Shares withheld for tax | −8,319 | $13.82 | $114,969 |
| Jul 22, 2026 | Nighan Warren JR Officer (SVP Quality and Regulatory) | Shares withheld for tax | −1,671 | $13.82 | $23,093 |
| Jul 22, 2026 | Piccinini Laura Officer (SVP International) | Shares withheld for tax | −4,506 | $13.82 | $62,273 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about AngioDynamics Inc.
Who is the CEO of AngioDynamics Inc.?
Eric Honroth has been AngioDynamics Inc.'s President and CEO since November 2026.
How many directors are on AngioDynamics Inc.'s board?
AngioDynamics Inc.'s board has 10 directors: Dennis S. Meteny, Eileen O'Shea Auen, Eric Honroth, Howard W. Donnelly, James C. Clemmer, Jan Stern Reed, Karen A. Licitra, Lorinda Burgess, Michael E. Tarnoff and Wesley Johnson.
Are AngioDynamics Inc. insiders buying or selling shares?
Over the last 12 months, AngioDynamics Inc. insiders made no open-market purchases and sold $654,695 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="angiodynamics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.